Scutellaria root, the root of Scutellaria baicalensis Georgi, is a crude drug used for inflammatory diseases. In our previous report, the combination of flavonoids contained in Scutellaria root have been found to inhibit PGE2 production more strongly than individual flavonoids. Here, to investigate the mechanism of the synergistic effect, we examined the effects of an equimolar mixture (F-mix) of baicalein (1), wogonin (2) and oroxylin A (3) on the production of PGE2 in LPS-treated J774.1 cells. Although 1 and 3 inhibited COX-2 activity, the F-mix showed no synergistic effect on COX-2 inhibition. Therefore, we investigated the steps leading to the activation of COX-2 protein. Compounds 1–3 and F-mix inhibited the expression of COX-2 protein. However, only 2 inhibited the expression of COX-2 mRNA among the flavonoids, and the F-mix showed no synergistic effect. Only 1 inhibited NF-κB translocation into the nucleus, and the F-mix showed no synergistic effect. Although 2 did not affect NF-κB translocation, it strongly inhibited NF-κB-dependent transcriptional activity, and the F-mix inhibited the activity slightly more than 2. Compounds 1–3 also inhibited NO production, and the F-mix showed a synergistic effect. However, the effects of each flavonoid on the expression of iNOS mRNA were not consistent with those on COX-2 mRNA. Because the flavonoids inhibit different steps in the production of PGE2 and NO, and their mixture did not show apparent synergistic effects in each step, we conclude that the synergistic effect of the flavonoid mixture reflects the total effect of the flavonoids inhibiting different steps in the NF-κB signalling pathway.
Scutellaria baicalensisFlavonoid Synergistic effect Prostaglandin E2Inflammation Nuclear factor-kappa B
This is a preview of subscription content, log in to check access.
This work was supported by JSPS KAKENHI grant number JP26460130, Keio Gijuku Academic Development Funds and MEXT-Supported Program for the Strategic Research Foundation at Private Universities. The authors thank Dr. Megumi Funakoshi-Tago for the valuable discussions.
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
Yoon SB, Lee YJ, Park SK, Kim HC, Bae H, Kim HM, Ko SG, Choi HY, Oh MS, Park W (2009) Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J Ethnopharmacol 125:286–290CrossRefPubMedGoogle Scholar
Huang WH, Lee AR, Yang CH (2006) Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci Biotechnol Biochem 70:2371–2380CrossRefPubMedGoogle Scholar
Kim EH, Shim B, Kang S, Jeong G, Lee JS, Yu YB, Chun M (2009) Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. J Ethnopharmacol 126:320–331CrossRefPubMedGoogle Scholar
Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W, Wei H, Sung M, Wang W, Li X (2003) Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 63:4037–4043PubMedGoogle Scholar
Lu Y, Joerger R, Wu C (2011) Study of the chemical composition and antimicrobial activities of ethanolic extracts from roots of Scutellaria baicalensis Georgi. J Agric Food Chem 59:10934–10942CrossRefPubMedGoogle Scholar
Oshima N, Narukawa Y, Hada N, Kiuchi F (2013) Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774. 1. J Nat Med 67:281–288CrossRefPubMedGoogle Scholar
Huang L, Fuchino H, Kawahara N, Narukawa Y, Hada N, Kiuchi F (2016) Application of a new method, orthogonal projection to latent structure (OPLS) combined with principal component analysis (PCA), to screening of prostaglandin E2 production inhibitory flavonoids in Scutellaria root. J Nat Med 70:731–739CrossRefPubMedGoogle Scholar
Cheng PY, Lee YM, Wu YS, Chang TW, Jin JS, Yen MH (2007) Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol 73:793–804CrossRefPubMedGoogle Scholar
Kimura Y, Sumiyoshi M (2011) Effects of baicalein and wogonin isolated from Scutellaria baicalensis roots on skin damage in acute UVB-irradiated hairless mice. Eur J Pharmacol 661:124–132CrossRefPubMedGoogle Scholar
Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS (2007) Baicalein inhibits IL-1β-and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway. Clin Mol Allergy 5:5–15CrossRefPubMedPubMedCentralGoogle Scholar
Yao J, Pan D, Zhao Y, Zhao L, Sun J, Wang Y, You QD, Xi T, Guo QL, Lu N (2014) Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway. Immunology 143:241–257CrossRefPubMedPubMedCentralGoogle Scholar
Yeh CH, Yang ML, Lee CY, Yang CP, Li YC, Chen CJ, Kuan YH (2014) Wogonin attenuates endotoxin-induced prostaglandin E2 and nitric oxide production via Src-ERK1/2-NFκB pathway in BV-2 microglial cells. Environ Toxicol 29:1162–1170CrossRefPubMedGoogle Scholar
Chen S, Xiong J, Zhan Y, Liu W, Wang X (2015) Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4–MyD88–TAK1-mediated NF-κB and MAPK signaling pathway. Cell Mol Neurobiol 35:523–531CrossRefPubMedGoogle Scholar
Chen YC, Yang LL, Lee TJF (2000) Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activation. Biochem Pharmacol 59:1445–1457CrossRefPubMedGoogle Scholar
Kleinert H, Pautz A, Linker K, Schwarz PM (2004) Regulation of the expression of inducible nitric oxide synthase. Euro J Pharmacol 500:255–266CrossRefGoogle Scholar
Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377–386CrossRefPubMedGoogle Scholar
Moncada SRMJ, Palmer RML, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMedGoogle Scholar
Karin M, Greten FR (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759CrossRefPubMedGoogle Scholar
Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN (2008) Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 76:967–973CrossRefPubMedPubMedCentralGoogle Scholar
Harasstani OA, Moin S, Tham CL, Liew CY, Ismail N, Rajajendram R, Harith HH, Zakaria ZA, Mohamad AS, Sulaiman MR, Israf DA (2010) Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells. Inflamm Res 59:711–721CrossRefPubMedGoogle Scholar
Chen LG, Hung LY, Tsai KW, Pan YS, Tsai YD, Li YZ, Liu YW (2008) Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase-2 gene expression in human lung epithelial cancer cells. Mol Nutr Food Res 52:1349–1357CrossRefPubMedGoogle Scholar
Furusawa J, Funakoshi-Tago M, Tago K, Mashino T, Inoue H, Sonoda Y, Kasahara T (2009) Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-κB p65 phosphorylation at serine 276. Cell Signal 21:778–785CrossRefPubMedGoogle Scholar
Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661–671CrossRefPubMedGoogle Scholar
Mitani T, Terashima M, Yoshimura H, Nariai Y, Tanigawa Y (2005) TGF-β1 enhances degradation of IFN-γ-induced iNOS protein via proteasomes in RAW 264.7 cells. Nitric Oxide 13:78–87CrossRefPubMedGoogle Scholar
Hwang D, Jang BC, Yu G, Boudreau M (1997) Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages. Biochem Pharmacol 54:87–96CrossRefPubMedGoogle Scholar
Kleinert H, Pautz A, Linker K, Schwarz PM (2004) Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500:255–266CrossRefPubMedGoogle Scholar